FTC Slams Surescripts' E-Prescribing Networks, Says 'Web Of Loyalty Contracts' Blocks Competition
Executive Summary
Surescripts maintained a monopoly on electronic prescription routing and eligibility markets through exclusive contracts with pharmacies and PBMs, complaint alleges.
You may also be interested in...
Anticompetitive Drug Rebates May Need FTC Rulemaking For Timely Reform, Commissioners Say
‘Rebate walls’ report heads to US Congress, but Democratic commissioners suggest FTC’s typical approach to curtailing such practices is too time consuming.
Pharma Enforcement Remains 'Priority Area' In FTC's 2021 Budget Request
US Federal Trade Commission has mainly focused in pay-for-delay cases over the past decade, but pricing strategies are an emerging area of attention; industry is paying close attention to potential enforcement in biosimilar market.
PBMs, Retail Pharmacies Vow To Cooperate On Electronic Prescribing
SureScripts, the retail pharmacy e-prescribing network, and RxHub, established by PBMs, are “complementary” organizations, RxHub CEO McLean tells House hearing. HHS plans to issue proposed electronic prescribing standards by year-end.